Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics–Related Cardiac Dysfunction

JACC: Cardiovascular Imaging

Volumn 9, Issue 10, 2016, Pages 1131-1141

  Narayan, Hari K ^a   French, Benjamin ^b   Khan, Abigail M ^b   Plappert, Theodore ^b   Hyman, David ^b   Bajulaiye, Akinyemi ^b   Domchek, Susan ^b,c   DeMichele, Angela ^b,c   Clark, Amy ^b,c   Matro, Jennifer ^b,c   Bradbury, Angela ^b,c   Fox, Kevin ^b,c   Carver, Joseph R ^b,c   Ky, Bonnie ^b,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cardio oncology; cardiotoxicity; echocardiography; mechanics

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; TRASTUZUMAB; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER THERAPEUTICS RELATED CARDIAC DYSFUNCTION; CARDIOTOXICITY; CARDIOVASCULAR PARAMETERS; CLINICAL OUTCOME; COHORT ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CIRCUMFERENTIAL STRAIN; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE COMPLIANCE; HEART VENTRICULAR ARTERIAL COUPLING; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INVASIVE MEASUREMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; AREA UNDER THE CURVE; BIOMECHANICS; BREAST NEOPLASMS; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; ELASTICITY; HEART CONTRACTION; HEART DISEASE; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; MECHANICAL STRESS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR;

ADULT; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BIOMECHANICAL PHENOMENA; BREAST NEOPLASMS; CARDIOTOXICITY; DOXORUBICIN; ECHOCARDIOGRAPHY; ELASTICITY; FEMALE; HEART DISEASES; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL CONTRACTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; STRESS, MECHANICAL; STROKE VOLUME; TIME FACTORS; TRASTUZUMAB; VENTRICULAR FUNCTION;

EID: 84963593710     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2015.11.024     Document Type: Article

References (32)

1. 1 Swain, S.M., Whaley, F.S., Ewer, M.S., Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97 (2003), 2869–2879.
2. 2 Felker, G.M., Thompson, R.E., Hare, J.M., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000), 1077–1084.
3. 3 Seidman, A., Hudis, C., Pierri, M.K., et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 20 (2002), 1215–1221.
4. 4 Shelburne, N., Adhikari, B., Brell, J., et al. Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst, 106, 2014, dju232.
5. 5 Altena, R., Perik, P.J., Van Veldhuisen, D.J., et al. Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol 10 (2009), 391–399.
6. 6 Negishi, K., Negishi, T., Hare, J.L., et al. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr 26 (2013), 493–498.
7. 7 Sawaya, H., Sebag, I.A., Plana, J.C., et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 5 (2012), 596–603.
8. 8 Ky, B., French, B., May Khan, A., et al. Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol 62 (2013), 1165–1172.
9. 9 Hedhli, N., Kalinowski, A.S., Russell, K., Cardiovascular effects of neuregulin-1/ErbB signaling: role in vascular signaling and angiogenesis. Curr Pharm Des 20 (2014), 4899–4905.
10. 10 Drafts, B.C., Twomley, K.M., D'Agostino, R., et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. J Am Coll Cardiol Img 6 (2013), 877–885.
11. 11 Theriault, R.L., Carlson, R.W., Allred, C., et al. Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 11 (2013), 753–761.
12. 12 Cheng, S., McCabe, E.L., Larson, M.G., et al. Left ventricular mechanical function: clinical correlates, heritability, and association with parental heart failure: heritability of left ventricular strain. Eur J Heart Fail 17 (2015), 44–50.
13. 13 Zhang, K.W., French, B., Khan, A.M., et al. Strain improves risk prediction beyond ejection fraction in chronic systolic heart failure. J Am Heart Assoc, 3, 2014, e000550.
14. 14 Nagata, Y., Takeuchi, M., Mizukoshi, K., et al. Intervendor variability of two-dimensional strain using vendor-specific and vendor-independent software. J Am Soc Echocardiogr 28 (2015), 630–641.
15. 15 St. John Sutton, M., Plappert, T., Core lab, no core lab or automated LVEF?. Eur J Echocardiogr 8 (2007), 239–240.
16. 16 Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39.e14.
17. 17 Piccart-Gebhart, M.J., Procter, M., Leyland-Jones, B., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353 (2005), 1659–1672.
18. 18 Cardinale, D., Colombo, A., Sandri, M.T., et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 114 (2006), 2474–2481.
19. 19 Voigt, J.-U., Pedrizzetti, G., Lysyansky, P., et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr 28 (2015), 183–193.
20. 20 Chen, C.-H., Fetics, B., Nevo, E., et al. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 38 (2001), 2028–2034.
21. 21 Liang, K.-Y., Zeger, S.L., Longitudinal data analysis using generalized linear models. Biometrika 73 (1986), 13–22.
22. 22 Pan, W., Akaike's information criterion in generalized estimating equations. Biometrics 57 (2001), 120–125.
23. 23 French, B., Saha-Chaudhuri, P., Ky, B., et al. Development and evaluation of multi-marker risk scores for clinical prognosis. Stat Methods Med Res 25 (2016), 255–271.
24. 24 Cheng, S., Larson, M.G., McCabe, E.L., et al. Age-and sex-based reference limits and clinical correlates of myocardial strain and synchrony: the Framingham Heart Study. Circ Cardiovasc Imaging 6 (2013), 692–699.
25. 25 Borlaug, B.A., Redfield, M.M., Melenovsky, V., et al. Longitudinal changes in left ventricular stiffness: a community-based study. Circ Heart Fail 6 (2013), 944–952.
26. 26 Plana, J.C., Galderisi, M., Barac, A., et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 27 (2014), 911–939.
27. 27 Hung, C.-L., Verma, A., Uno, H., et al. Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am Coll Cardiol 56 (2010), 1812–1822.
28. 28 Cho, G.-Y., Marwick, T.H., Kim, H.-S., et al. Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 54 (2009), 618–624.
29. 29 Farsalinos, K.E., Daraban, A.M., Ünlü, S., et al. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr 28 (2015), 1171–1181.e2.
30. 30 Kutyifa, V., Kloppe, A., Zareba, W., et al. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy. J Am Coll Cardiol 61 (2013), 936–944.
31. 31 Kraigher-Krainer, E., Shah, A.M., Gupta, D.K., et al. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 63 (2014), 447–456.
32. 32 Royston, P., Altman, D.G., Sauerbrei, W., Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25 (2006), 127–141.